Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Vascular Diseases: early-phase trial registry
10 of 20 indexed Peripheral Vascular Diseases trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #848 of 28,707 conditions by registered trial count.
20 US clinical trials · 10 currently recruiting · #848 of 28,707 conditions by registered trial count
Peripheral Vascular Diseases: 20 US clinical trials tracked, 10 recruiting.
Peripheral Vascular Diseases is the subject of 20 registered US clinical trials on ClinicalTrials.gov, 10 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is Northwestern University, running 4 of these trials.
Enrollment posture brief
Registry condition peripheral-vascular-diseases
OPEN 10 | RECR 50% | LATE 2 | EARLY 6 | RANK #848 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Peripheral Vascular Diseases lists 10 open slots (50% of 20 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Vascular Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Vascular Diseases is recruiting above its size-band peers.
10 of 20 indexed trials (50%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Peripheral Vascular Diseases research.
Northwestern University accounts for 4 of 20 trials (20%). 14 distinct sponsors appear on at least one study for this condition label.
-
Typical Peripheral Vascular Diseases enrolment sits around 200 participants.
Median target enrolment is 200 among the 20 trials that report a genuine target (sentinel values excluded). 5 of those (25%) plan for fewer than 100 participants.
-
Peripheral Vascular Diseases research is mostly interventional.
16 interventional and 4 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
20 total, page 1 of 1
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
Boston Scientific Corporation
NCT04674969
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1
Virginia Commonwealth University
NCT04916327
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
Brigham and Women's Hospital
NCT06300450
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 2
Virginia Commonwealth University
NCT04922762
Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 3
Virginia Commonwealth University
NCT04916340
SMART Exercise for PAD
Northwestern University
NCT06032065
MRI Guided Management of Occlusive Peripheral Arterial Disease
The Methodist Hospital Research Institute
NCT06782100
Fisetin to Reduce Senescence and Mobility Impairment in PAD
Northwestern University
NCT06399809
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
University of Nebraska
NCT06319339
The Effects of ATLAS Therapy on Nitric Oxide Bioavailability in Patients With Intermittent Claudication
Louis Messina
NCT04800692
Virtual Diabetes Group Visits Across Health Systems
University of Chicago
NCT06094491
Magnetic Resonance Imaging to Identify Characteristics of Plaque Build-Up in People With Peripheral Arterial Disease
Northwestern University
NCT00520312
Reducing Risk Factors in Peripheral Arterial Disease
Northwestern University
NCT00217919
GORE-TEX PROPATEN Vascular Graft Study
W.L.Gore & Associates
NCT00205790
GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)
W.L.Gore & Associates
NCT00541307
Implementation of Telemedicine for Patient With Lower Extremity Wounds
University of California, Davis
NCT04440839
Distributed Registry
Stanford University
NCT03898570
Alfimeprase for Thrombolysis in Acute Peripheral Arterial Occlusion
ARCA Biopharma
NCT00073554
Peripheral Nerve Blocks for Above-the-knee Amputations
University of Florida
NCT03404180
Natural Vascular Scaffold (NVS) Therapy for Treatment of Atherosclerotic Lesions (Activate I)
Alucent Biomedical
NCT04188262
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Vascular Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Vascular Diseases trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Vascular Diseases page
20 registered trials, 10 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 10 Peripheral Vascular Diseases trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Northwestern University sponsors the most Peripheral Vascular Diseases trials on record, review their full trial history before evaluating a specific study. See Northwestern University's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Vascular Diseases condition card totals 20 registered trials; most-linked intervention Obturator nerve blocks; top US site state Illinois. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.